RR
Rajesh Ranjan
About Rajesh Ranjan
Data last updated:
Rajesh Ranjan is a Director at Dme Development Limited (since 2023) and Director at Iffco-Tokio General Insurance Company Limited (since 2023). The companies operate in Infrastructure and Utilities and Financial Services. The largest current company by reported revenue is Dme Development Limited at ₹2,211 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Apr 2023 | 2020 | ₹2,211 Cr (FY 2025) | Active | |
| Director | 18 Apr 2023 | 2000 | Active |
Board colleagues of Rajesh Ranjan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Ranjan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Ranjan
Rajesh Ranjan currently holds 2 directorships: Dme Development Limited (Director, since 15 Apr 2023, revenue ₹2,211 Cr (FY 2025)); Iffco-Tokio General Insurance Company Limited (Director, since 18 Apr 2023).
Rajesh Ranjan was first appointed on 15 Apr 2023 as Director at Dme Development Limited.
The current boards of Rajesh Ranjan's companies include Alok Deepankar (Dme Development Limited), Ananta Manohar Meduri Chakravartula (Dme Development Limited), Neti Ravi Vijay Venkat Murali Krishna Rajendrakumar (Dme Development Limited), Prachi Mittal (Dme Development Limited), Rupesh Kumar Srivastava (Dme Development Limited), Sudha Damodar (Dme Development Limited), among others.